Home » Rosetta Genomics Closes on Public Offering, Raises $27.5M

Rosetta Genomics Closes on Public Offering, Raises $27.5M

Aug 08, 2012
|
staff reporter

NEW YORK (GenomeWeb News) – Rosetta Genomics said today it has closed its public offering, raising $27.5 million in gross proceeds.

The firm offered 5.5 million shares at $5 per share. Aegis Capital was the sole book-running manager for the offering. Rosetta granted the underwriter a 45-day option to purchase up to 825,000 additional shares to cover any overallotments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Cloud Ready

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

The Science and Policy Connection

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

The New Yeast

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

This Week in Cell

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.

What's Popular?

In Gene Silencing/Gene Editing

  1. UPDATE: CRISPR Stakeholders Seek Reversal of Patent Interference Proceeding Decision

  2. UC Riverside Team Wins $14.9M DARPA Grant for Genetic Mosquito Control Research

  3. Researchers Design, Construct Genome-Wide Sequence-Verified Arrayed CRISPR Library

  4. Cas1-Cas2 Integrase Structures Enable Bacteria to Adapt to New Viruses

  5. Christiana Care, NovellusDx Ink Licensing Deal for Gene-Editing Tech

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.